Labshake search
Citations for R&D Systems :
251 - 300 of 3575 citations for 3 Phenoxybenzoic Acid Phenoxy 13C6 99% 100 Ug Ml In Acetonitrile since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... and 100 ng/ml Noggin (R&D systems, Cat#1967-NG), and the medium was changed every 2 days until DIV6 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 100 ng/ml recombinant FGF10 (R&D Systems, Minneapolis, MN, USA), 10 nM Gastrin I (Thermo Fisher Scientific) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 100 ng/mL rhTGFβ1 (R&D Systems Cat#240-B-002), 100 ng/mL rhNOGGIN (produced in-house ...
-
bioRxiv - Immunology 2024Quote: ... and 100 U/ml IL-2 (R&D Systems, Minneapolis, MN). NK-92 cells were passaged in 2–3 day interval to maintain the cell density at 2.5 × 105 – 1 × 106 cells/ml ...
-
bioRxiv - Developmental Biology 2024Quote: ... and 100 ng/mL CHO-derived R-spondin1 (R&D System)] ...
-
bioRxiv - Immunology 2022Quote: ... or 1 μg/ml goat IgG anti-human TIM-3 (R&D systems) and alone or in combination of 5 mM Metformin (SIGMA) ...
-
bioRxiv - Cell Biology 2022Quote: ... commercial Sigma-1 R antibody to 3 µg/ml (MAB1076, R&D systems) chicken Calreticulin (Abcam ...
-
bioRxiv - Synthetic Biology 2020Quote: ... 10 ng/mL transforming growth factor beta 3 (TGF-β3, R&D Systems) and 100nM dexamethasone12,27 to make implantable cartilage constructs11 ...
-
bioRxiv - Immunology 2024Quote: ... containing 1 ng/mL IL-3 (R&D Systems in Minneapolis, MN, USA) at 37°C with 5% CO2.
-
bioRxiv - Cancer Biology 2022Quote: ... human cytokines (1 ng/ml stem cell factor, 100 ng/ml thrombopoietin, 13.5 ng/ml interleukin 9, 10 ng/ml interleukin 6; all cytokines from R&D Systems), and 1XPenicillin-Streptomycin (Gibco ...
-
bioRxiv - Bioengineering 2021Quote: ... containing 200 ng/mL Nodal or 100 ng/mL Activin A (both obtained from R&D Systems) and 3 μM CHIR99021 (Stemgent ...
-
bioRxiv - Immunology 2022Quote: ... and 100 ng/ml recombinant mouse IL-28B/IFN-λ3 (R&D Systems #1789-ML-025/CF). For select experiments ...
-
bioRxiv - Cell Biology 2022Quote: ... BMDMs were treated with 100 ng/mL mouse IFNγ or 5 U/mL IFNα (R&D Systems) for 2 ...
-
bioRxiv - Immunology 2024Quote: ... and 50 ng/mL TNF (R&D Systems, #410-MT-010, 100 µg/mL stock in PBS) diluted in PBS or PBS ...
-
bioRxiv - Immunology 2024Quote: ... and 50 ng/mL TNF (R&D Systems, #410-MT-010, 100 µg/mL stock in PBS) diluted in DMEM (Thermo Fisher Scientific ...
-
bioRxiv - Immunology 2024Quote: ... and 50 ng/mL TNF (R&D Systems, #410-MT-010, 100 µg/mL stock in PBS) diluted in DMEM (Thermo Fisher Scientific ...
-
bioRxiv - Microbiology 2021Quote: ... 1 U/ml penicillin/streptomycin) with 3 ng/ml recombinant mouse GM-CSF (rGM-CSF; R&D Systems or BioLegend)) at a concentration of 2.5 x 105 cells/ml in 150 x 15 mm petri plates at 37°C with 5% CO2 ...
-
bioRxiv - Cell Biology 2023Quote: Immunohistochemistry was performed with the following antibodies: Cleaved Caspase 3 (rabbit, R&D Systems, MAB835, 1:100), Hopx (mouse ...
-
bioRxiv - Immunology 2019Quote: ... with rat anti-mouse IL-18 (1 μg/ml; D047-3; R&D Systems), rabbit anti-human IL-18 (0.2 μg/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... cocultures were treated with 3 μg/ml IL1α-neutralizing antibody (#MAB4001, R&D Systems) or isotype control antibody (#400902 ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
bioRxiv - Microbiology 2020Quote: ... 1000 U/mL IFN-β (PBL Assays) and 100 ng/mL IFN-λ (IL-29) (R&D Systems) were incubated on cells for 16 h (unless otherwise indicated).
-
bioRxiv - Cell Biology 2020Quote: ... 100 ng/ml Recombinant Human/Mouse/Rat Activin A (R&D Systems) and 3μM CHIR99021 (Stemgent) ...
-
bioRxiv - Cell Biology 2021Quote: ... or MMP-9 at (1,10 & 100 ng/ml) (R&D Systems Europe) in protease buffer (50mM HEPES (pH 7.5 ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 100 ng/ml recombinant mouse (rm) SCF (R&D Systems) and 50 ng/ml rmTPO (R&D Systems) ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with 100 ng/ml recombinant WNT3A (R&D Systems).
-
bioRxiv - Neuroscience 2022Quote: ... cultures were treated with IGF2 (R&D Systems; 100 ng ml−1), the PI3K/Akt inhibitor LY294002 (Sigma ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/mL Shh-C24II (R&D Systems, Minneapolis, MN, USA) and 1 μM purmorphamine (Millipore ...
-
bioRxiv - Microbiology 2020Quote: ... or IFN-γ (200 U/ml, R&D systems 285-IF-100). 3 days post-stimulation whole cell lysates were generated.
-
bioRxiv - Immunology 2022Quote: ... or NKG2D neutralizing antibody (5 µg/ml, R&D Systems, MAB139-100); ILC1-like cells demonstrated cytotoxic effect on HFs with 600 cells per well ...
-
bioRxiv - Immunology 2022Quote: ... or function-blocking NKG2D (5 µg/ml, R&D Systems, MAB139-100) antibodies ...
-
bioRxiv - Microbiology 2020Quote: ... and IFNγ (10ng/ml; R&D Systems catalog# 285-IF-100, respectively). After 5 hours of incubation with LPS/IFNγ ...
-
bioRxiv - Genetics 2020Quote: ... and 100 ng/ml recombinant human SCF (R&D systems #255-SC) (referred to as X-VIVO complete medium) ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 100 ng/mL recombinant human Activin A protein (R&D Systems). For neurectoderm-directed differentiation ...
-
bioRxiv - Bioengineering 2022Quote: ... follistatin of 100 ng/mL (769-FS-025/CF, R&D system) and a cocktail of myostatin and follistatin (overall 50 ng/mL each ...
-
bioRxiv - Cell Biology 2022Quote: ... and Wnt3a (100 ng/ml, R&D Systems, 1324-WN-002/CF). Treated cells were incubated for 48 hours and Axin2 gene expression was evaluated using the protocol described above ...
-
bioRxiv - Cell Biology 2022Quote: ... and 100 ng ml-1 FGF8a (4745-F8-050, R&D Systems). On day 16-17 ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of IL-2 (100 U/ml, R&D Systems) and IL-7 (50 ng/ml ...
-
bioRxiv - Neuroscience 2023Quote: ... and fibroblast growth factor 8 (FGF8; 100 ng/mL, R&D Systems). Upon appearance of rosette-like structures (day 14) ...
-
bioRxiv - Cancer Biology 2023Quote: ... murine NRG1 (100 ng mL−1, R&D Systems 9875-NR-050), murine EREG (500 ng mL−1 ...
-
bioRxiv - Immunology 2023Quote: ... recombinant human CCL2 (100 ng/ml, 279-MC-010; R&D Systems) was added to the cells immediately before loading them into the flow chamber and the CCL2 concentration was maintained during the initial 4 min of the assay.
-
bioRxiv - Neuroscience 2023Quote: ... 10 ng/ml NGF (R&D systems, cat. no. 256-GF-100), 1 mg/ml mouse laminin (Invitrogen ...
-
bioRxiv - Neuroscience 2023Quote: ... but supplemented with BMP inhibitor Noggin (100 ng/ml, R&D Systems) 44,79 and Y27632 (10 µM ...
-
bioRxiv - Microbiology 2023Quote: ... or IFN-γ (200 U/ml, R&D systems 285-IF-100). 24 hours post-stimulation whole cell lysates were generated.
-
bioRxiv - Bioengineering 2023Quote: ... the medium was supplemented with 100 ng/mL Noggin (R&D Systems) and 10 μM SB431542 (Fujifilm Wako ...
-
bioRxiv - Bioengineering 2023Quote: ... with the addition of 100 ng/mL Activin A (R&D Systems). After 1 to 3 days ...
-
bioRxiv - Immunology 2024Quote: ... and 100 ng/ml human recombinant APRIL/TNFSF-13 (R&D systems). Human healthy donor peripheral blood mononuclear cells (PBMC ...
-
bioRxiv - Neuroscience 2021Quote: ... coated plates in N4 media (N3 with 0.05uM Retinoic acid, 2ng/ml BDNF (R&D Systems #248-BDB) and 2 ng/ul GDNF (R&D Systems #212-GD)) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 200 ng/ml of BMP4 (314-BP-010, 100 ng/ml of SCF (R&D Systems, 255-SC-050), 50 ng/ml of EGF (R&D Systems ...
-
bioRxiv - Cell Biology 2023Quote: ... 9-cis retinoic acid and all-trans retinoic acid (both R&D Systems) were each dissolved in 100% DMSO ...